Stocks and Investing Stocks and Investing
Fri, September 10, 2021
Thu, September 9, 2021

Paul Matteis Downgraded (VRTX) to Hold and Decreased Target to $213 on, Sep 9th, 2021


Published on 2024-10-27 17:52:23 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold and Decreased Target from $244 to $213 on, Sep 9th, 2021.

Paul has made no other calls on VRTX in the last 4 months.



There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021


These are the ratings of the 11 analyists that currently disagree with Paul


  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $202 on, Tuesday, September 7th, 2021
  • Brian Skorney of "Baird" Maintained at Buy and Held Target at $240 on, Sunday, August 1st, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $248 on, Friday, July 30th, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $323 on, Friday, July 30th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Sell with Increased Target to $175 on, Friday, July 30th, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $331 on, Monday, June 14th, 2021
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $307 on, Friday, June 11th, 2021
  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $281 on, Friday, June 11th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
Contributing Sources